Enhabit (NYSE:EHAB) Reaches New 1-Year High – Should You Buy?

Shares of Enhabit, Inc. (NYSE:EHAB) reached a new 52-week high during trading on Wednesday . The stock traded as high as $13.68 and last traded at $13.6650, with a volume of 656213 shares. The stock had previously closed at $13.66.

Analyst Ratings Changes

Several research firms recently commented on EHAB. Wolfe Research set a $12.00 target price on shares of Enhabit in a report on Thursday, January 8th. UBS Group restated a “neutral” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Leerink Partners raised their price objective on Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a research note on Monday, February 23rd. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a “buy” rating in a report on Tuesday, January 13th. Finally, Truist Financial set a $13.80 target price on Enhabit in a research note on Monday, February 23rd. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $13.57.

Enhabit Trading Up 0.0%

The firm’s 50 day moving average is $12.09 and its 200 day moving average is $9.87. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market capitalization of $693.09 million, a PE ratio of -151.83 and a beta of 1.56.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. The business had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. As a group, equities analysts predict that Enhabit, Inc. will post 0.22 EPS for the current year.

Insider Buying and Selling at Enhabit

In related news, EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the sale, the executive vice president directly owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This trade represents a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 3.40% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of EHAB. Hsbc Holdings PLC grew its position in shares of Enhabit by 56.6% in the 4th quarter. Hsbc Holdings PLC now owns 37,735 shares of the company’s stock worth $350,000 after buying an additional 13,633 shares during the last quarter. Corient Private Wealth LLC raised its holdings in shares of Enhabit by 49.2% during the fourth quarter. Corient Private Wealth LLC now owns 14,967 shares of the company’s stock valued at $138,000 after acquiring an additional 4,933 shares in the last quarter. Empowered Funds LLC lifted its stake in Enhabit by 11.1% in the fourth quarter. Empowered Funds LLC now owns 262,221 shares of the company’s stock worth $2,418,000 after acquiring an additional 26,287 shares during the period. Polymer Capital Management US LLC bought a new stake in Enhabit in the fourth quarter valued at $169,000. Finally, Eversept Partners LP bought a new stake in Enhabit in the fourth quarter valued at $2,015,000.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.